Aimed Bio

0009K0 · KQ · Healthcare / Biotechnology

18,310.00KRW-900.00 (-4.69%)

Price History

Full chart

Market Stats

Previous Close19,210.00

Open19,580.00

Day Range18,310.00 – 20,600.00

52-Week Range17,400.00 – 80,200.00

Volume219.35K

Market Cap1.43T

P/E (TTM)0.00

Forward P/E0.00

Dividend Yield0.00%

50-Day Avg23,258.80

200-Day Avg40,807.45

About

Aimed Bio Inc. develops therapeutic solutions for patients with brain diseases, including neuro-oncological and degenerative diseases. Its multidisciplinary platform offers antibody-drug conjugates, blood-brain barrier penetration, brain immune modulation, and patient-derived models (PDC/PDX). Aimed Bio Inc. was founded in 2018 and is based in Seoul, South Korea.

Company Details

SectorHealthcare
IndustryBiotechnology
CEOMr. Nam-Gu Her Ph.D.
Headquarters10F 11F MK Tower, Seoul, South Korea, 05835, Korea
Websitehttps://www.aimedbio.com

Leadership

Dr. Do-Hyun Nam M.D., Ph.D.Founder, CTO & Chairman · b. 1963
Mr. Nam-Gu Her Ph.D.CEO & Inside Director · b. 1982
Mr. Munyeong HuhCFO & Inside Director · b. 1989
Mr. Taekyoung KimMD & COO
Mr. Byeongkwi Min Ph.D.Head of R&D and MD

Earnings

Report Date	Dec 31, 2025	Mar 31, 2026	Jun 30, 2026
EPS Estimate	-	-	-
EPS Actual	544.35	-31.09	167.00
Surprise	-	-	-
Timing	-	-	-

Key Statistics & Ratios

Market Cap1.43T

Enterprise Value1.37T

Trailing P/E0.00

Forward P/E0.00

Price / Sales21.47

Price / Book0.00

Revenue (TTM)66.79B

Gross Profit (TTM)66.79B

EBITDA25.83B

Profit Margin57.79%

Operating Margin42.19%

Return on Equity25.93%

Return on Assets9.85%

Shares Outstanding64.16M

Shares Float22.61M

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%